Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Safety, supply, and suits--litigation and the vaccine industry.

Kesselheim A.

N Engl J Med. 2011 Apr 21;364(16):1485-7. doi: 10.1056/NEJMp1102182. No abstract available.

2.

Vaccine liability in the Supreme Court: forging a social compact.

Kraemer JD, Gostin LO.

JAMA. 2011 May 11;305(18):1900-1. doi: 10.1001/jama.2011.615. No abstract available.

PMID:
21558521
3.

The National Childhood Vaccine Injury Act and the supreme court's interpretation.

Blake V.

Virtual Mentor. 2012 Jan 1;14(1):31-4. doi: 10.1001/virtualmentor.2012.14.1.hlaw1-1201. No abstract available.

PMID:
23116914
4.

Pharmaceutical promotion to physicians and First Amendment rights.

Kesselheim AS, Avorn J.

N Engl J Med. 2008 Apr 17;358(16):1727-32. doi: 10.1056/NEJMsb0708920. No abstract available.

PMID:
18420505
5.

The Cutter incident, 50 years later.

Offit PA.

N Engl J Med. 2005 Apr 7;352(14):1411-2. No abstract available.

PMID:
15814877
6.

Determinants of vaccine supply.

[No authors listed]

Natl Bur Econ Res Bull Aging Health. 2011;(3):2-3. No abstract available.

PMID:
22207917
7.

Access to safety data--stockholders versus prescribers.

Pfeffer MA, Bowler MB.

N Engl J Med. 2011 Jul 7;365(1):1-3. doi: 10.1056/NEJMp1104699. Epub 2011 Jun 29. No abstract available.

9.

Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.

Smirniotopoulos A.

Rev Law Soc Change. 2012;35(4):793-862.

PMID:
22363960
10.

A strike against preemption.

[No authors listed]

Nat Biotechnol. 2009 May;27(5):397. doi: 10.1038/nbt0509-397.

PMID:
19430422
11.

Shattuck lecture. Innovation, regulation, and the FDA.

Hamburg MA.

N Engl J Med. 2010 Dec 2;363(23):2228-32. doi: 10.1056/NEJMsa1007467. No abstract available.

12.

Revisiting Factor VIII cases: is it time for an agency adjudication system?

Su YC.

Food Drug Law J. 2008;63(4):943-61. No abstract available.

PMID:
19601390
13.

Vaccine compensation proposals abound on Capitol Hill.

Sun M.

Science. 1986 Jul 25;233(4762):415. No abstract available.

PMID:
3487830
14.

The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902.

Lilienfeld DE.

Perspect Biol Med. 2008 Spring;51(2):188-98. doi: 10.1353/pbm.0.0010.

PMID:
18453724
15.

The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.

Vladeck DC.

Cornell Law Rev. 2008 Jul;93(5):981-1002. No abstract available.

PMID:
18618967
16.

Impossible? Outlawing state safety laws for generic drugs.

Glantz LH, Annas GJ.

N Engl J Med. 2011 Aug 25;365(8):681-3. doi: 10.1056/NEJMp1107832. Epub 2011 Aug 10. No abstract available.

17.

Ask your doctor: Justice Holmes and the marketplace of ideas.

Weissmann G.

FASEB J. 2009 Dec;23(12):4039-42. doi: 10.1096/fj.09-1201ufm. No abstract available.

PMID:
19948522
18.

Pharmaceutical patent life-cycle management after KSR v. Teleflex.

Furrow ME.

Food Drug Law J. 2008;63(1):275-320. No abstract available.

PMID:
18561462
19.

Eugenics and compulsory sterilization laws: providing redress for victims of a shameful era in United States history.

Silver MG.

George Washington Law Rev. 2004 Apr;72(4):862-92. No abstract available.

PMID:
16211742
20.

Higher First Amendment hurdles for public health regulation.

Outterson K.

N Engl J Med. 2011 Aug 18;365(7):e13. doi: 10.1056/NEJMp1107614. Epub 2011 Aug 3. No abstract available.

Supplemental Content

Support Center